Exchange: NASDAQ·Updated 07:30 PM EDT
PYXS logo

PYXS Pyxis Oncology Inc

$3.23
$0.09
(2.71%)
Today
Closed $3.23
$0.0003
(0.01%)
After Hours
Reported EarningsAug 13
Mkt Cap$269.41M
Vol211,991.00

About PYXS

Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. The firm focuses on the development of product candidates to directly kill tumor cells and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. The company was founded by David Steinberg, Shaan C. Gandhi, and John L. Flavin on June 11, 2018 and is headquartered in Boston, MA.
36

Bearish Sentiment

How do you feel about PYXS?

Advertisement|Remove ads.